Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

Granisetron Kabi concentrate for solution for infusion 1mg/ml

Approval Number

SIN14409P

Drug Name

Granisetron Kabi concentrate for solution for infusion 1mg/ml

Product Name

Granisetron Kabi concentrate for solution for infusion 1mg/ml

Approval Date

September 23, 2013

Registrant

FRESENIUS KABI (SINGAPORE) PTE LTD

Licence Holder

FRESENIUS KABI (SINGAPORE) PTE LTD

Regulatory Information

Registrant

FRESENIUS KABI (SINGAPORE) PTE LTD

Licence Holder

FRESENIUS KABI (SINGAPORE) PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INFUSION, SOLUTION CONCENTRATE

Route of Administration

INTRAVENOUS

Medical Information

ATC Code

A04A A02

ATC Item Name

xa 04 a a 02

Manufacturer Information

Pharmaceutical Manufacturer

FRESENIUS KABI (SINGAPORE) PTE LTD

Manufacturers

LABESFAL – Laboratórios Almiro S.A. (Fresenius Kabi Group)

Active Ingredients

Ingredient Name

Granisetron Hydrochloride 1.12mg/ml eqv Granisetron

Strength

1mg/ml

Drug MonographGranisetron

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy